Invasive Candidiasis Diagnosis and Treatment

Diagnostic Considerations

A tissue biopsy with a positive Candida culture represents direct evidence of invasive fungal infection and is considered definitive for diagnosis, according to the Intensive Care Medicine guidelines 1, 2.
Diagnosis of Candida infection by tissue biopsy is made on the basis of either quantitative culture of more than 10^5 organisms per gram of tissue or the presence of yeasts on microscopy pending culture results, as recommended by the Intensive Care Medicine guidelines 1.
The Fungitell assay has a pooled sensitivity of 75-80% and specificity of approximately 80% for diagnosing invasive candidiasis, making it less reliable than direct tissue culture, as stated by the Praxis Medical Insights guidelines 3.

When Candida is identified at sterile sites, speciation and sensitivity testing should be routine to guide appropriate antifungal therapy, as recommended by the Intensive Care Medicine guidelines 1, 2.
Different Candida species have varying susceptibilities to antifungal agents, so speciation of the tissue culture isolate is more important than additional biomarker testing, according to the Intensive Care Medicine and Clinical Microbiology and Infection guidelines 1, 4.
Begin appropriate antifungal therapy based on the tissue culture result and patient's clinical condition, as recommended by the Clinical Microbiology and Infection guidelines 4.

A positive tissue culture for Candida provides direct evidence of infection at the sampled site, while Fungitell is an indirect marker that cannot specify the type of fungus or location of infection, as stated by the Intensive Care Medicine and Praxis Medical Insights guidelines 1, 3.
False positive Fungitell results are common, particularly in ICU patients, those on hemodialysis, and those receiving albumin or intravenous immunoglobulin infusions, as noted by the Praxis Medical Insights guidelines 3.
Avoid unnecessary diagnostic testing that will not change management decisions and may increase healthcare costs, as recommended by the Praxis Medical Insights guidelines 3.